期刊文献+

磷酸特地唑胺的合成新方法 被引量:8

A New Synthetic Route Toward Tedizolid Phosphate
下载PDF
导出
摘要 以(5R)-3-(4-溴-3-氟苯基)-5-羟甲基噁唑烷-2-酮为起始原料,在[Pd Cl2(dppf)]·CH2Cl2催化下与联硼酸频那醇酯反应得到硼化物,继而与5-溴-2-(2-甲基-2H-四唑-5-基)吡啶进行Suzuki反应得到特地唑胺,收率82.9%。分别考察了催化体系对硼化反应和Suzuki反应的影响,确定了较佳的反应条件。特地唑胺与二苄基N,N-二异丙基亚磷酰胺反应得到二苄基保护的磷酸特地唑胺,随后经Pd/C脱苄得到磷酸特地唑胺,总收率66.2%。 Tedizolid with a yield of 82. 9% was synthesized by the Suzuki coupling reaction of 5-bromo-2-( 2-methyl-2H-tetrazol-5-yl) pyridine and( 5R)-3-( 4-bromo-3-fluorophenyl)-5-( hydroxymethyl)-2-oxazolidinone which was prepared from bis( pinacolato) diboron using 1,1'-bis( diphenylphosphino) ferrocene-palladium( Ⅱ)dichloride dichloromethane complex as the catalyst. The effect of the catalytic system on the reaction of the borylation reaction and Suzuki reaction was investigated respectively,and the optimum reaction conditions were determined. Tedizolid phosphate was obtained by reaction of tedizolid with dibenzyl N, Ndiisopropylphosphoramidite,and subsequent debenzylation with Pd / C. The total yield is 66. 2%.
出处 《应用化学》 CAS CSCD 北大核心 2015年第11期1240-1245,共6页 Chinese Journal of Applied Chemistry
基金 江苏省博士后基金(1101152C)~~
关键词 (5R)-(溴氟苯基)羟甲基噁唑烷酮硼化物 溴-(甲基-2H-四唑基)吡啶 二苄基N N-二异丙基亚磷酰胺 磷酸特地唑胺 borides of(5R)-(bromo-fluorophenyl)-(hydroxymethyl)-oxazolidin-one bromo-(methyl-2H-tetrazol-yl) pyridine dibenzyl N N-diisopropylphosphoramidite tedizolid phosphate
  • 相关文献

参考文献14

  • 1周青桐,赵临襄.磷酸泰地唑胺[J].中国药物化学杂志,2014,24(6):499-500. 被引量:8
  • 2徐晓刚,汪复.一种抗革兰阳性菌感染的新型口恶唑烷酮类抗菌药物——泰地唑胺[J].中国感染与化疗杂志,2014,14(5):455-459. 被引量:5
  • 3Im W B, Choi S H, Park J Y, et al. Discovery of Torezolid as a Novel 5-Hydroxymethyl-oxazolidinone Antibacterial Agent [J]. Eur J Med Chem,2011,46( 4 ) :1027-1039.
  • 4李在杰,任元彬,曹宗焕,等.新型嗯唑烷酮衍生物:中国,200480037612.2[P],2004.12.17.
  • 5李在杰,任元彬,曹宗焕,等.嗯唑烷酮衍生物以及含有该衍生物的药物组合物:中国,201010508824.1[P],2004-12-17.
  • 6Rhee J K, Im W B, Cho C H, et al. Novel Oxazolidinones Derivatives : W0,2005058886 [ P ] ,2005-06-30.
  • 7Costello C A, Simson J A, Duguid R J, et al. Methods for Preparaing Oxazolidinones and Compositions Containing Them: WO ,2010042887 [ P] ,2010-04-15.
  • 8卡丽·A·科斯特洛,杰克莱恩·A·西姆森,罗伯特·J·杜吉德,等.制备嗯唑烷酮类的方法及含有嗯唑烷酮类的组合物:中国,200980140144.4[P],2009.10-09.
  • 9Ding C Z, Lu G, Combrink K,et al. Bicyclic Nitroimidazoles Covalently Linked to Substituted Phenyl Oxazolidinones : WO, 2009120789[ P] ,2009-10-01.
  • 10Hubsehwerlen C,Speeklin J L,Baeschlin D K,et al. Oxazolidinone-quinolone Hybrid Antibioties:WO,2005058888[ P], 2005-06-30.

二级参考文献13

  • 1Moellering RC Jr. Tedizolid , a novel oxazolidinone for Grampositive infections[J]. Clin Infect Dis. 2014.58 (Suppl 1) : s ls3 .
  • 2Itani KM, Shorr AF. FDA guidance for ABSSSI trials: implications for conducting and interpreting clinical trials[J]. Clin Infect Dis.2014. 58(Supp11l :s4-s9 .
  • 3Stryjewski ME. Corey GR. Methicillin-resistant Staphylococcus aureus: anevolving pathogen [J]. Clin Infect Dis ? 2014. 58(Suppl 1) : sI0-sI9.
  • 4Rodvold KA, McConeghy KW. Methicillin-resistant Staphylococcus aureus therapy: past. present. and future [J]. Clin Infect Dis.2014. 58(Suppl1) :s20-s27 .
  • 5Lodise TP, Drusano GL. Use of pharmacokinetic/pharmacodynamic systems analysesto inform dose selection of tedizolid phosphate[J]. Clin Infect Dis.2014. 58(Suppl1) :s28-s34.
  • 6Locke JB, Zurenko GE, Shaw KJ, et al. Tedizolid for the management of human infections: in vitro characteristics[J]. Clin Infect Dis,2014,58(SuppI1l :s35-s42.
  • 7a'Riordan W, Green S, Mehra P. et al. Tedizolid phosphate for the management of acute bacterial skin and skin structure infections: efficacy summary [J]. Clin Infect Dis,2014, 58 (Suppl 1) : s43-s50.
  • 8Das D. Tulkens PM, Mehra P.et al. Tedizolid phosphate for the management of acute bacterial skin and skin structure infections: safety surnmary]]]. Clin Infect Dis, 20 14.58 CSuppl 1):s51-s57.
  • 9Flanagan SD. Bien PA. Munoz KA. et al. Pharmacokinetics of tedizolid following oral administration: single and multipledose, effect of food. and comparison of two solid forms of the prodrug[J]. Pharmacotherapy, 2014, 34 (3) : 240-250.
  • 10IM W B,CHOI S H,PARK J Y,et al.Discovery of torezolid as a novel 5-hydroxymethyl-oxazolidinone antibacterial agent[J].Eur J Med Chem,2011,46(4):1027-1039.

共引文献9

同被引文献25

引证文献8

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部